Last reviewed · How we verify
The Treatment group
The Treatment group works by targeting the underlying cause of the disease.
The Treatment group works by targeting the underlying cause of the disease. Used for Treatment of acute ischemic stroke.
At a glance
| Generic name | The Treatment group |
|---|---|
| Sponsor | Beijing Tiantan Hospital |
| Drug class | Unknown |
| Modality | Small molecule |
| Therapeutic area | Neurology |
| Phase | FDA-approved |
Mechanism of action
Although the exact mechanism is not well-documented, it is believed to involve a complex interplay of cellular and molecular processes.
Approved indications
- Treatment of acute ischemic stroke
Common side effects
- Hemorrhage
- Infection
- Cardiac arrest
Key clinical trials
- A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP) (PHASE2)
- Rosacea and Ivermectin (PHASE2)
- Attitude and Success Rate of Women With Pelvic Organ Prolapse on Self-management of Vaginal Pessary (NA)
- MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003) (PHASE1)
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- The Impact of Equine-Assisted Therapy on Mental Health and Addictive Behaviors in Patients Receiving Addiction Treatment (NA)
- Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS (NA)
- Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- The Treatment group CI brief — competitive landscape report
- The Treatment group updates RSS · CI watch RSS
- Beijing Tiantan Hospital portfolio CI